Loading…
Ambar Protein Industries (BSE 519471)₹202.35−5.00%Edible Oil
In the Mar 2026 quarter (standalone), Ambar Protein Industries reported sales of ₹147 Cr, up 14.9% from Mar 2025, and net profit of ₹2.45 Cr, down 0.8% year on year. For the year to Mar 2026, sales were ₹500 Cr and net profit ₹6.98 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93.11 | 68.53 | 85.57 | 89.36 | 92.85 | 88.79 | 112 | 128 | 117 | 112 | 125 | 147 |
| Expenses | 90.47 | 66.88 | 81.74 | 90.07 | 89.89 | 84.57 | 107 | 124 | 115 | 109 | 121 | 142 |
| Operating Profit | 2.61 | 1.58 | 3.83 | −0.76 | 2.95 | 4.24 | 4.83 | 3.80 | 2.15 | 2.52 | 3.25 | 4.13 |
| OPM % | 2.8% | 2.3% | 4.5% | −0.8% | 3.2% | 4.8% | 4.3% | 3.0% | 1.8% | 2.3% | 2.6% | 2.8% |
| Other Income | 0.11 | 0.11 | 0.11 | 0.30 | 0.21 | 0.21 | 0.18 | 0.19 | 0.18 | 0.17 | 0.18 | 0.21 |
| Interest | 0.63 | 0.62 | 0.68 | 0.49 | 0.55 | 0.55 | 0.56 | 0.57 | 0.52 | 0.44 | 0.49 | 0.54 |
| Depreciation | 0.34 | 0.27 | 0.40 | 0.35 | 0.33 | 0.33 | 0.47 | 0.22 | 0.34 | 0.35 | 0.35 | 0.37 |
| Profit before tax | 1.74 | 0.79 | 2.85 | −1.27 | 2.27 | 3.56 | 3.97 | 3.19 | 1.46 | 1.89 | 2.58 | 3.42 |
| Tax % | 27.4% | 2.5% | 45.0% | −64.9% | 24.5% | 24.6% | 29.1% | 22.1% | 48.9% | −5.3% | 29.7% | 27.9% |
| Net Profit | 1.25 | 0.77 | 1.55 | −0.44 | 1.71 | 2.68 | 2.81 | 2.47 | 0.74 | 1.99 | 1.80 | 2.45 |
| EPS (Rs) | 2.20 | 1.37 | 2.72 | −0.79 | 3.00 | 4.69 | 4.91 | 4.32 | 1.31 | 3.49 | 3.16 | 4.29 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 168 | 195 | 206 | 231 | 284 | 313 | 339 | 344 | 335 | 420 | 500 | 500 |
| Expenses | 167 | 193 | 203 | 227 | 278 | 304 | 330 | 338 | 327 | 405 | 488 | 488 |
| Operating Profit | 2.01 | 3.01 | 3.01 | 4.01 | 6.01 | 8.01 | 9.01 | 7.01 | 7.01 | 16.04 | 12.02 | 12.05 |
| OPM % | 1.2% | 1.3% | 1.5% | 1.7% | 2.1% | 2.5% | 2.8% | 2.1% | 2.2% | 3.7% | 2.4% | 2.4% |
| Other Income | 0.00 | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 0.74 |
| Interest | 0.99 | 0.99 | 0.99 | 0.99 | 2.99 | 2.99 | 2.99 | 2.99 | 1.99 | 1.99 | 1.99 | 1.99 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.41 |
| Profit before tax | 0.99 | 1.99 | 2.99 | 2.99 | 2.99 | 3.99 | 5.99 | 3.99 | 3.99 | 12.99 | 8.99 | 9.35 |
| Tax % | 36.0% | 2.0% | 27.0% | 28.0% | 55.0% | 13.0% | 24.9% | 28.9% | 24.0% | 25.9% | 24.9% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.39 | −0.14 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.99 | 1.99 | 1.99 | 1.99 | 0.99 | 2.99 | 3.99 | 2.99 | 2.99 | 9.96 | 6.98 | 6.98 |
| EPS (Rs) | 1.52 | 4.20 | 3.75 | 3.54 | 2.18 | 6.01 | 7.76 | 4.90 | 5.49 | 16.83 | 12.26 | 12.25 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.99 | 5.98 | 5.98 | 5.98 | 5.98 | 5.97 | 5.98 | 5.97 | 5.98 | 5.98 | 5.98 | 5.98 |
| Reserves | −3.01 | −1.01 | 0.00 | 2.01 | 4.01 | 5.01 | 9.02 | 13.03 | 16.03 | 19.02 | 29.05 | 36.08 |
| Borrowings | 6.03 | 8.03 | 10.03 | 18.05 | 24.10 | 27.10 | 27.10 | 33.14 | 29.11 | 26.10 | 26.08 | 26.09 |
| Other Liabilities | 4.02 | 5.03 | 7.01 | 4.97 | 18.91 | 10.97 | 8.00 | 11.98 | 10.95 | 10.95 | 9.95 | 13.93 |
| Total Liabilities | 13.03 | 17.03 | 23.02 | 31.01 | 53.00 | 49.05 | 50.10 | 64.12 | 62.07 | 61.05 | 71.06 | 82.08 |
| Fixed Assets | 4.02 | 6.02 | 6.01 | 6.02 | 7.02 | 22.06 | 21.07 | 21.08 | 20.05 | 19.06 | 18.06 | 18.07 |
| CWIP | 0.00 | 0.00 | 0.00 | 5.98 | 15.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 9.01 | 12.01 | 17.01 | 19.01 | 31.02 | 26.99 | 29.03 | 44.04 | 42.02 | 41.99 | 51.01 | 63.02 |
| Inventories | 4.46 | 7.67 | 9.36 | 8.35 | 21.59 | 14.35 | 17.39 | 26.68 | 19.49 | 20.04 | 20.44 | 38.68 |
| Trade receivables | 0.90 | 1.23 | 4.47 | 1.41 | 1.45 | 2.04 | 3.47 | 9.04 | 14.27 | 13.96 | 20.25 | 10.15 |
| Cash & equivalents | 2.08 | 1.06 | 1.97 | 3.31 | 1.14 | 2.94 | 1.57 | 1.42 | 1.19 | 1.14 | 1.20 | 1.30 |
| Total Assets | 13.03 | 17.03 | 23.02 | 31.01 | 53.00 | 49.05 | 50.10 | 64.12 | 62.07 | 61.05 | 71.06 | 82.08 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.99 | −0.99 | −2.99 | 0.99 | 0.99 | 2.99 | 0.99 | −2.99 | 5.98 | 6.97 | 1.99 | 2.99 |
| Cash from investing activity | 0.00 | −1.01 | 0.00 | −5.01 | −10.02 | −1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −1.01 |
| Cash from financing activity | −0.99 | 0.99 | 2.99 | 5.99 | 6.98 | 0.00 | −1.99 | 1.99 | −5.99 | −6.99 | −1.99 | −1.99 |
| Net cash flow | 0.00 | −0.99 | 0.99 | 0.99 | −1.99 | 0.99 | −0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 0.29 | 1.52 | 0.76 | 5.99 | 10.52 | 1.31 | 0.83 | 0.67 | 0.73 | 0.68 | 1.14 | 1.56 |
| Free cash flow | 0.99 | −1.99 | −2.99 | −4.99 | −8.98 | 1.99 | 0.00 | −2.99 | 4.98 | 5.98 | 0.99 | 0.99 |
| CFO / OP % | 68.9% | −36.1% | −100.1% | 50.9% | 45.0% | 58.9% | 22.9% | −17.1% | 107.9% | 102.9% | 29.9% | 56.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 1 | 2 | 7 | 2 | 1 | 2 | 3 | 9 | 14 | 14 | 17 | 6 |
| Inventory days | 13 | 19 | 20 | 17 | 38 | 21 | 23 | 33 | 24 | 25 | 21 | 31 |
| Days payable | 9 | 10 | 8 | 5 | 9 | 2 | 4 | 8 | 6 | 7 | 2 | 6 |
| Cash conversion cycle | 4 | 10 | 18 | 13 | 29 | 19 | 21 | 33 | 30 | 31 | 34 | 30 |
| Working capital days | −9 | −5 | −2 | −5 | −10 | −9 | −3 | 2 | 3 | 5 | 11 | 14 |
| ROCE % | 28.0% | 18.0% | 22.0% | 17.0% | 13.0% | 15.0% | 18.0% | 19.0% | 13.0% | 13.0% | 28.0% | 18.0% |
For the Mar 2026 quarter, Ambar Protein Industries reported sales of ₹147 Cr, up 14.9% year on year and net profit of ₹2.45 Cr, down 0.8% year on year. The operating margin was 2.8%.
Ambar Protein Industries' sales for the year to Mar 2026 were ₹500 Cr; over the last twelve months they were ₹500 Cr.
Net profit for the year to Mar 2026 was ₹6.98 Cr, and ₹6.98 Cr over the last twelve months. Earnings per share over the same trailing period were ₹12.25.
Ambar Protein Industries reported borrowings of ₹26.09 Cr at Mar 2026, against cash and equivalents of ₹1.30 Cr.
Cash from operations was ₹2.99 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.99 Cr.